LUPIN
Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, dialectology, asthma, paediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One, V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others.
Disc: Invested, please do you own research
코멘트:
closed the trade after stock moved out of rising channel
코멘트:
Important to keep tracking your original ideas
now back in track close to key resistance area
disc: invested back one stock back in rising channel
now back in track close to key resistance area
disc: invested back one stock back in rising channel
Join me on Twitter @bhatiashivendra to stay updated on my thoughts and insights on stocks, financial assets, and markets. I focus on research-based analysis and avoid hype. As an experienced investor in a diverse range of assets, I invite you to conduct